AUTHOR=Li Zaifang , Zhang Yanhui , Hoene Miriam , Fritsche Louise , Zheng Sijia , Birkenfeld Andreas , Fritsche Andreas , Peter Andreas , Liu Xinyu , Zhao Xinjie , Zhou Lina , Luo Ping , Weigert Cora , Lin Xiaohui , Xu Guowang , Lehmann Rainer 

TITLE=Diagnostic Performance of Sex-Specific Modified Metabolite Patterns in Urine for Screening of Prediabetes

JOURNAL=Frontiers in Endocrinology

VOLUME=13

YEAR=2022

URL=https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2022.935016

DOI=10.3389/fendo.2022.935016

ISSN=1664-2392

ABSTRACT=<sec><title>Aims/Hypothesis</title><p>Large-scale prediabetes screening is still a challenge since fasting blood glucose and HbA<sub>1c</sub> as the long-standing, recommended analytes have only moderate diagnostic sensitivity, and the practicability of the oral glucose tolerance test for population-based strategies is limited. To tackle this issue and to identify reliable diagnostic patterns, we developed an innovative metabolomics-based strategy deviating from common concepts by employing urine instead of blood samples, searching for sex-specific biomarkers, and focusing on modified metabolites.</p></sec><sec><title>Methods</title><p>Non-targeted, modification group-assisted metabolomics by liquid chromatography–mass spectrometry (LC-MS) was applied to second morning urine samples of 340 individuals from a prediabetes cohort. Normal (<italic>n</italic> = 208) and impaired glucose-tolerant (IGT; <italic>n</italic> = 132) individuals, matched for age and BMI, were randomly divided in discovery and validation cohorts. ReliefF, a feature selection algorithm, was used to extract sex-specific diagnostic patterns of modified metabolites for the detection of IGT. The diagnostic performance was compared with conventional screening parameters fasting plasma glucose (FPG), HbA<sub>1c</sub>, and fasting insulin.</p></sec><sec><title>Results</title><p>Female- and male-specific diagnostic patterns were identified in urine. Only three biomarkers were identical in both. The patterns showed better AUC and diagnostic sensitivity for prediabetes screening of IGT than FPG, HbA<sub>1c</sub>, insulin, or a combination of FPG and HbA<sub>1c</sub>. The AUC of the male-specific pattern in the validation cohort was 0.889 with a diagnostic sensitivity of 92.6% and increased to an AUC of 0.977 in combination with HbA<sub>1c</sub>. In comparison, the AUCs of FPG, HbA<sub>1c</sub>, and insulin alone reached 0.573, 0.668, and 0.571, respectively. Validation of the diagnostic pattern of female subjects showed an AUC of 0.722, which still exceeded the AUCs of FPG, HbA<sub>1c</sub>, and insulin (0.595, 0.604, and 0.634, respectively). Modified metabolites in the urinary patterns include advanced glycation end products (pentosidine-glucuronide and glutamyl-lysine-sulfate) and microbiota-associated compounds (indoxyl sulfate and dihydroxyphenyl-gamma-valerolactone-glucuronide).</p></sec><sec><title>Conclusions/Interpretation</title><p>Our results demonstrate that the sex-specific search for diagnostic metabolite biomarkers can be superior to common metabolomics strategies. The diagnostic performance for IGT detection was significantly better than routinely applied blood parameters. Together with recently developed fully automatic LC-MS systems, this opens up future perspectives for the application of sex-specific diagnostic patterns for prediabetes screening in urine.</p></sec>